BHM vs ITRM Comparison

Bluerock Homes Trust Inc owns and operates single-family properties that generate rental and other property-related income through the leasing of units to a diverse base of tenants. The properties are located in Sunbelt and the Western United States. The company's principal business objective is to generate attractive risk-adjusted investment returns by assembling a portfolio of institutional residential properties including single-family homes, build-to-rent communities, and other residential communities, located across a diverse group of growth markets. The company has two reportable segments scattered single-family homes and residential communities. The company generates the majority of its revenue from the Scattered single-family homes segment.

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.